首页|期刊导航|癌症生物学与医学(英文版)|Toward the precision use of Chinese PARP inhibitors in ovarian cancer:clinical progress,resistance mechanisms,and future perspectives
癌症生物学与医学(英文版)2026,Vol.23Issue(6):788-795,8.DOI:10.20892/j.issn.2095-3941.2026.0102
Toward the precision use of Chinese PARP inhibitors in ovarian cancer:clinical progress,resistance mechanisms,and future perspectives
Toward the precision use of Chinese PARP inhibitors in ovarian cancer:clinical progress,resistance mechanisms,and future perspectives
摘要
引用本文复制引用
Jing Yu,Maochen Li,Yuhan Zhu,Shengnan Wang,Yuzhao Jiang,Wei Cui,Lingying Wu..Toward the precision use of Chinese PARP inhibitors in ovarian cancer:clinical progress,resistance mechanisms,and future perspectives[J].癌症生物学与医学(英文版),2026,23(6):788-795,8.基金项目
This work was supported by grants from the CAMS Innovation Fund for Medical Sciences[CIFMS](Grant No.2025-12M-KJ-004)and the National Natural Science Foundation of China(Grant No.81772272). (Grant No.2025-12M-KJ-004)